adamantan-1-amine

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: adamantan-1-amine
• 化学式: C30H51N3
• 分子量: 453.7
• InChiKey: KSGKTMHXUAVYFL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.74
• 重原子数：
  33
• 可旋转键数：
  0
• 环数：
  10.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  78.1
• 氢给体数：
  3
• 氢受体数：
  3

文献信息

• USE OF COMPOUNDS FOR THE TREATMENT OF PAIN
  申请人：Akron Molecules AG

  公开号：EP2846788A1

  公开（公告）日：2015-03-18
• PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS
  申请人：Imprimis Pharmaceuticals Inc.

  公开号：EP3310439A1

  公开（公告）日：2018-04-25
• [EN] USE OF COMPOUNDS FOR THE TREATMENT OF PAIN<br/>[FR] UTILISATION DE COMPOSÉS POUR LE TRAITEMENT DE LA DOULEUR
  申请人：AKRON MOLECULES GMBH

  公开号：WO2013167743A1

  公开（公告）日：2013-11-14

  The present invention relates to new therapies to treat pain and related diseases, as well as pharmaceutical compounds for use in said therapies.
• [EN] PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS<br/>[FR] COMPOSITIONS PHARMACEUTIQUES POUR DES APPLICATIONS ANESTHÉSIOLOGIQUES
  申请人：IMPRIMIS PHARMACEUTICALS INC

  公开号：WO2016205533A1

  公开（公告）日：2016-12-22

  Pharmaceutical compositions and methods are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, a beta-blocker and antiemetic. Methods for fabricating the compositions and using them for anesthesiological applications are also described.